Review of Current and Potential Treatments for Chronic Hepatitis B Virus Infection

Abstract: Chronic hepatitis B virus (HBV) infection remains a major global health burden. Millions of people are at risk for complications of chronic HBV infection, despite […]

Overview of Current and Emerging Treatments for Hepatitis B Virus Infection

G&H Have there been any recent trends in the incidence of hepatitis B virus infection in the United States? RK The incidence of hepatitis B […]

Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy

Abstract: Chronic hepatitis B virus (HBV) infection remains a global health burden, affecting an estimated 257 million people, and is associated with substantial morbidity and […]

Management Approaches to Hepatitis B Virus Vaccination Nonresponse

Abstract: Background: Despite the availability of hepatitis B virus (HBV) vaccination, HBV remains a cause of significant morbidity and mortality around the world. Immunologic response […]

Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection

G&H Currently, what is the burden of hepatitis B virus infection in the United States? RK Population surveys have suggested that there are between 700,000 and […]

Elimination of Hepatitis B and C Virus Infections

G&H Is it feasible to eliminate hepatitis B and C virus infections in the United States? AA Hepatitis B virus (HBV) and hepatitis C virus (HCV) […]

Hepatitis B Virus Infection and Organ Transplantation

Abstract: Hepatitis B virus (HBV) infection remains an important cause of liver disease and continues to present several unique challenges in organ transplantation despite the […]

HBV/HCV Coinfection and Possible Reactivation of HBV Following DAA Use

G&H How does coinfection affect hepatitis B and C virus? Are the diseases more severe or resistant? RG When a person has active hepatitis B […]

A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women

Abstract: Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) remains high even with the proper use of active-passive immunoprophylaxis in newborns. Mothers with significant viremia […]

Highlights in Hepatitis B Virus Treatment From the 2016 Annual Meeting of the American Association for the Study of Liver Diseases

From the 2016 Annual Meeting of the American Association for the Study of Liver Diseases November 11-15, 2016 • Boston, Massachusetts Tenofovir Alafenamide Is […]

Gastro-Hep News

Gastroenterology & Hepatology Volume 13, Issue 1, January 2017 Vonoprazan Vs Lansoprazole for the Treatment of Duodenal or Gastric Ulcers Vonoprazan, a potassium-competitive acid blocker used […]